NYSE:VTR - New York Stock Exchange, Inc. - US92276F1003 - REIT - Currency: USD
Why VENTAS INC (NYSE:VTR) qualifies as a high growth stock. A fundamental and technical analysis of (NYSE:VTR).
VTR is likely to gain from rising healthcare expenditures among senior citizens. Accretive investments in the research portfolio and solid balance sheet bode well.
Railroad stocks got a boost from news of a trade deal, raising investor hopes that there will not be a prolonged slowdown in imports. Investors should be cautious about buying into this rally, as it could take time for volumes to recover. Weekend progress toward resolving the trade spat between the United States and China has markets rallying, and railroad stocks are among the big winners.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes? Let's find out.
VTR's Q1 results reflect higher same-store cash NOI due to SHOP same-store average occupancy growth.
We recently published a list of Why These 15 Real Estate Stocks Are Surging In 2025. In this article, we are going to take a look at where SBA Communications Corp (NASDAQ:SBAC) stands against other real estate stocks that are surging in 2025. For years, real estate stocks have been a source of anxiety for […]
We recently published a list of Why These 15 Real Estate Stocks Are Surging In 2025. In this article, we are going to take a look at where Ventas Inc (NYSE:VTR) stands against other real estate stocks that are surging in 2025. For years, real estate stocks have been a source of anxiety for investors […]
We recently published a list of 11 Best Buy-the-Dip Stocks to Buy Now. In this article, we are going to take a look at where Watsco, Inc. (NYSE:WSO) stands against other best buy-the-dip stocks to buy now. As volatility rises, AllianceBernstein believes that staying invested remains a strategic priority to capture the long-term return potential in a […]
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) delivered FFO and revenue surprises of 2.44% and 4.08%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: OHI
While MPW's Q1 earnings are likely to have benefited from the favorable healthcare industry trends, exposure to certain troubled operators may have hurt it.
SBAC's Q1 results reflect significant growth in site-development revenues. However, higher costs and interest expenses ail.
ARE's Q1 results reflect decent leasing activity and higher rental rates. However, lower occupancy and higher interest expenses impacted the performance.
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Lower rates on its foreign exchange hedge contracts and high interest expenses are likely to have impacted BIP's Q1 results despite its diversified infrastructure assets.
IRM's Q1 earnings are likely to have been hurt by shifts in data storage through non-paper-based technologies despite solid data center demand.
KIM's Q1 earnings are likely to have gained from its grocery-anchored, diverse premium properties in high-growth markets and focus on mixed-use assets.
We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend stocks for long-term income. Passive income, which refers to money earned with little ongoing effort, was once largely the […]
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ventas (VTR) have what it takes? Let's find out.
WPC's Q1 results are likely to reflect gains from a high-quality, diverse single-tenant net lease commercial portfolio amid strong demand for industrial assets.
EXR's Q1 results are likely to reflect gains from high brand value, a solid presence in key cities and expansionary efforts.
BXP's Q1 earnings are likely to have been boosted by healthy demand for premium office assets. However, high competition and interest expenses might have hurt.
WELL's Q1 earnings are likely to have benefited from the rise in the aging population and its healthcare expenditure. Yet, high interest expenses are a concern.
SBAC's Q1 earnings are likely to have been affected by ongoing consolidation in the wireless industry and higher churn.
We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Match Group, Inc. (NASDAQ:MTCH) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, […]